1.
Where, in accordance with the provisions of this Regulation, the Committee for Proprietary Medicinal Products or the Committee for Veterinary Medicinal Products is required to evaluate a medicinal product, the Committee shall appoint one of its members to act as rapporteur for the coordination of the evaluation, taking into consideration any proposal from the applicant for the choice of a rapporteur. The Committee may appoint a second member to act as co-rapporteur. The Committee shall ensure that all its members undertake the role of rapporteur or co-rapporteur.
← Article 53 · All articles · 2. →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.